Infinium Pharmachem Share Price
Small Cap | Pharmaceuticals and health care | NSE: INFINIUM
₹296.80 
-2.20 (-0.74 %)
Last Updated: 30 Apr 2025 03:40 PM
BULLISH
Overview
Open (₹) 306.50
High (₹) 307.00
Low (₹) 296.00
Prev. Close (₹) 299.00
Volume 10,000
VWAP (₹) 236.25
ROCE (%) 25.57
Industry P/E 46.55
TTM P/E 41.11
P/B Ratio 7.03
Market Cap (₹) Cr.413.03
Dividend Yield (%)--
EPS (₹) 8.12
ROE19.22%
Sales Growth (%) 18.75
Profit Growth (%)17.17
Day Range
307.00307.00
52 Week Range
178.05392.50
Historical Returns
Returns (6M)
-8.96 %
Returns (1Y)
34.54 %
Returns (3Y)
301.62 %
Returns (5Y)
301.62 %
Returns (6M)
-8.96 %
Returns (1Y)
34.54 %
Returns (3Y)
301.62 %
Returns (5Y)
301.62 %
SWOT Analysis
- Company with no debt
- Increasing Annual Revenue for Past 2 Years
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
BULLISHRSI 38.54
MFI 42.32
ATR 10.54
Commodity Channel Index 55.03
ROC125 -30.44
ROC21 5.82
Williams %R -23.73
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 236.66 | 236.83 | 237.16 | 236.33 | 236.16 | 235.83 | 235.66 |
| Week Ago | 232.96 | 236.93 | 244.86 | 225.03 | 221.06 | 213.13 | 209.16 |
| Month Ago | 228.49 | 236.52 | 240.54 | 224.47 | 216.44 | 212.42 | 204.39 |
EMA & SMA
296.80
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 232.40
9 Day 234.48
10 Day 234.01
12 Day 233.15
14 Day 233.71
20 Day 229.41
26 Day 229.69
50 Day 243.50
100 Day 277.13
200 Day 266.05
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| RUSHABH BHARATBHAI | bulk | Sell | 18th Apr, 2023 | ₹153.34 | 38,000 | NSE |
| MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Sell | 18th Apr, 2023 | ₹146.00 | 50,000 | NSE |
| SWASTIKA INVESTMART LIMITED | bulk | Sell | 17th Apr, 2023 | ₹148.55 | 30,000 | NSE |
| SWASTIKA INVESTMART LIMITED | bulk | Buy | 17th Apr, 2023 | ₹141.50 | 50,000 | NSE |
| SHRIPAL V VORA (HUF) | bulk | Buy | 17th Apr, 2023 | ₹148.45 | 36,000 | NSE |
| PRAGNA HITESH LUNAGARIYA | bulk | Buy | 17th Apr, 2023 | ₹141.50 | 76,000 | NSE |
| MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Buy | 17th Apr, 2023 | ₹141.50 | 50,000 | NSE |
| DHARAMSHI GORDHANBHAI PATEL | bulk | Buy | 17th Apr, 2023 | ₹141.50 | 35,000 | NSE |
| BHUPESH VAHALABHAI PATEL | bulk | Buy | 17th Apr, 2023 | ₹141.50 | 45,000 | NSE |
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 2nd Aug, 2023 | Bonus issue in the ratio of 1:1 of Rs. 10/-. | 13th Sept, 2023 | 13th Sept, 2023 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 25th Apr, 2025 | NSE India | Significant movement in price has been observed in Infinium Pharmachem Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
| 19th Apr, 2025 | NSE India | Infinium Pharmachem Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__ |
| 15th Apr, 2025 | NSE India | Infinium Pharmachem Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
| 24th Mar, 2025 | NSE India | Infinium Pharmachem Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 24th Mar, 2025 | NSE India | INFINIUM PHARMACHEM LIMITED has informed the Exchange about Closure of Trading Window |
| 4th Mar, 2025 | NSE India | Infinium Pharmachem Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 |
| 19th Dec, 2024 | NSE India | The Exchange had sought clarification from Infinium Pharmachem Limited for the quarter ended 30-Sep-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI -2. Segment details not submitted The response of the Company is enclosed. |
| 11th Dec, 2024 | NSE India | The Exchange has sought clarification from Infinium Pharmachem Limited for the quarter ended 30-Sep-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI -2. Segment details not submitted The response of the Company is awaited. |
| 14th Nov, 2024 | NSE India | Infinium Pharmachem Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024. |
| 14th Nov, 2024 | NSE India | Infinium Pharmachem Limited has informed the Exchange regarding Board meeting held on November 14, 2024. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Others | To consider other business matters. | 8th Nov, 2024 | 14th Nov, 2024 |
| Audited Results | -- | 11th Jun, 2024 | 29th May, 2024 |
| Quarterly Results | -- | 20th Oct, 2023 | 27th Oct, 2023 |
| Bonus issue | -- | 24th Jul, 2023 | 2nd Aug, 2023 |
| Audited Results | -- | 5th May, 2023 | 17th May, 2023 |
Share Holding Pattern
| Owner Name | Mar, 2025 | Nov, 2024 | Sept, 2023 | ||
|---|---|---|---|---|---|
| Promoter Group | 65.24% | 65.24% | 73.05% | 0% | 0% |
| Foreign Institutions + | 0% | 0% | 0% | 0% | 0% |
| Domestic Institutions + | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 34.76% | 34.76% | 26.95% | 0% | 0% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Infinium Pharmachem
Infinium Pharmachem is a Public Limited Listed company incorporated on 21/11/2003 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ2003PLC043218 and registration number is 043218. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 122.36 Cr. and Equity Capital is Rs. 13.92 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
2003
Managing Director
Mr. Sanjaykumar Viththalbhai Patel
NSE Symbol
INFINIUM
Infinium Pharmachem Management
| Name | Designation |
|---|---|
| Mr. Sanjaykumar Viththalbhai Patel | Managing Director |
| Mr. Pravin Bhadabhai Madhani | Executive Director |
| Mr. Mitesh Lavjibhai Chikhaliya | Executive Director |
| Mr. Vaishakhi Ambrishbhai Shukla | Independent Director |
| Mr. Tarun Ratilal Dobariya | Independent Director |
| Mr. Keyur Jagdishchandra Shah | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,39,630.15 | ₹1,832.30  ₹1,805.50(1.48%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,61,590.72 | ₹6,087.00  ₹6,108.00(-0.34%) | ₹3,725.550 - ₹6,448.750 |
| Cipla | ₹1,25,192.34 | ₹1,550.10 ₹1,541.50(0.56%) | ₹1,310.050 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,12,431.58 | ₹3,322.00 ₹3,322.70(-0.02%) | ₹2,513.050 - ₹3,589.950 |
| Mankind Pharma | ₹1,01,712.98 | ₹2,465.30 ₹2,556.90(-3.58%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Infinium Pharmachem
What is the share price of Infinium Pharmachem?
The share price of Infinium Pharmachem on 30th Apr, 2025 is ₹ 296.80.
What is 52W high and 52W low share price of Infinium Pharmachem?
The highest and lowest 52W share prices of Infinium Pharmachem are ₹ 392.500 and ₹ 178.050
What is the market cap of Infinium Pharmachem?
The market capitalization of Infinium Pharmachem as of 30th Apr, 2025 is ₹ 413.03 Crores
What is the P/E ratio of Infinium Pharmachem?
The current P/E ratio of Infinium Pharmachem as of 30th Apr, 2025 is 46.55
What is the PB ratio of Infinium Pharmachem?
The PB ratio of Infinium Pharmachem as of 30th Apr, 2025 is 7.03
Top Gainers
₹78.00
₹65.00 (0.20%)
₹121.03
₹100.86 (0.20%)
₹13.15
₹11.00 (0.20%)
₹1.88
₹1.57 (0.20%)
Top Losers
₹107.95
₹123.00 (-0.12%)
₹0.50
₹0.56 (-0.11%)
₹24.55
₹28.11 (-0.13%)
₹3.34
₹3.80 (-0.12%)
Market Indices
Sensex
₹80,242.24
₹80,288.38 (0.00%)